Table 3. Demographic and clinical characteristics between HBV/HCV coinfected and HCV monoinfected patients.
| Characteristic | HBV/HCV, n = 14 | HCV, n = 108 | p-value |
| Age in y, mean±SD | 51.0±12.7 | 46.5±13.1 | 0.229 |
| Male, n (%) | 7(50.0) | 58(53.7) | 0.794 |
| HCV-RNA as log10 IU/mL, mean±SD | 6.0±1.3 | 6.1±1.1 | 0.814 |
| ALT as U/L, IQR | 85(41–114) | 65(35–141) | 0.740 |
| AST as U/L, IQR | 65(40–143) | 60(36–115) | 0.865 |
| GGT as U/L, IQR | 64.5(34–119) | 53(26–149) | 0.701 |
| TB as μmol/L, IQR | 17.5(9.8–27.3) | 15(10.0–20.8) | 0.685 |
| DB as μmol/L, IQR | 8(5.0–13.3) | 6(5–10) | 0.672 |
| PLT as 10^9/L, mean±SD | 122.1±65.4 | 148.0±71.5 | 0.200 |
| APRI level, IQR | 1.5(0.6–4.9) | 1.4(0.6–3.3) | 0.821 |
Abbreviations: ALT, alanine transaminase; APRI, aspartate aminotransferase to platelet ratio index; AST, aspartate aminotransferase; DB, direct bilirubin; GGT, gamma-glutamyltransferase; HBV, hepatitis B virus; HCV, hepatitis C virus; IQR, interquartile range; PLT, platelet; SD, standard deviation; TB, total bilirubin.